Found 54 matching trials
Multi-CAR-T Cells Targeting B Cell Lymphomas
PHASE1This study aims to evaluate safety and efficacy of a combination of 4th gen...
Location
Shenzhen Geno-Immune Medical Institute
A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
PHASE1This study is a single-armed, open-label,multicenter Phase 1/2 study to eva...
Location
Multiple Locations
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma
PHASE2This study consists of two sequential treatment phases. In the first phase,...
Location
Institute of Hematology & Blood Diseases Hospital
Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma
PHASE1This is a single arm study to evaluate the efficacy and safety of Sequentia...
Location
Hebei Yanda Ludaopei Hospital
Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma
PHASE1This is a single arm study to evaluate the efficacy and safety of CD19 and ...
Location
Chongqing University Cancer Hospital
National Project on Vaccines, COVID-19 and Frail Patients
N/AThis is a multicentre observational study with the aim of evaluating the an...
Location
IRCCS Istituto Tumori Giovanni Paolo II
Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.
EARLY_PHASE1A Clinical Study on the Safety and Effectiveness of CD19/CD22 Chimeric Anti...
Location
The First People's Hospital of Jingzhou
Study of Sequential CAR-T Cell Treating Leukemia Children
PHASE2The investigators will conduct a phase II clinical trial of sequential chim...
Location
Beijing Boren Hospital
Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
PHASE1This is a gene transfer study for patients with a type of blood cancer call...
Location
Texas Children's Hospital
Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL
PHASE1Clinical Trial for the Safety and Efficacy of Sequential CD19 and CD22 CAR-...
Location
The First Affiliated Hospital, College of Medicine, Zhejiang University